Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphateThomas Putz, Reinhold Ramoner, Hubert Gander, et al.Experimental Hematology|January 29, 2005
The cyclopentenone prostaglandin PGA2 costimulates the maturation of human dendritic cellsMartin Thurnher, Thomas Putz, Hubert Gander, et al.Journal of Clinical Immunology|December 29, 2004
Monitoring of CD4+ and CD8+ T-cell responses after dendritic cell-based immunotherapy using CFSE dye dilution analysisThomas Putz, Reinhold Ramoner, Hubert Gander, et al.Blood|October 21, 2004
Dendritic-cell activation by secretory phospholipase A2Reinhold Ramoner, Thomas Putz, Hubert Gander, et al.Cancer Immunology, Immunotherapy : CII|September 2, 2006
Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cellsThomas Putz, Reinhold Ramoner, Hubert Gander, et al.Cancer Immunology, Immunotherapy : CII|November 16, 2006
Antigen-independent immune responses after dendritic cell vaccinationNicolai Leonhartsberger, Reinhold Ramoner, Thomas Putz, et al.The Prostate|January 27, 2004
Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cellsKarina Pfeil, Iris E Eder, Thomas Putz, et al.Cancer Immunology, Immunotherapy : CII|July 1, 2006
IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responsesClaudia Falkensammer, Karin Jöhrer, Hubert Gander, et al.Methods in Molecular Medicine|December 9, 2004
Generation of clinical-grade monocyte-derived dendritic cells using the CliniMACS systemThomas Putz, Hubert Gander, Reinhold Ramoner, et al.Cancer Immunology, Immunotherapy : CII|May 27, 2005
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamideLorenz Höltl, Reinhold Ramoner, Claudia Zelle-Rieser, et al.Pageof 2